Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-09

Clinical Trial Update: Evaluate the Safety and Efficacy of Naftifine Hydrochloride Cream 2% and Naftin® Cream 2% in Patients With Tinea Pedis [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and efficacy of Naftifine hydrochloride 2% cream and Naftin 2% cream for tinea pedis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naftifine Hydrochloride Cream 2% (naftifine hydrochloride)
  • Naftin Cream 2% (naftifine hydrochloride)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Tinea Pedis | Phase 1 | Status: COMPLETED